Back to Results
First PageMeta Content
Sunitinib / Genentech / Renal cell carcinoma / Schistocyte / Food and Drug Administration / Thrombocytopenia / Microangiopathic hemolytic anemia / Medicine / Pharmacology / Bevacizumab


July[removed]IMPORTANT DRUG WARNING SUBJECT: Microangiopathic Hemolytic Anemia (MAHA) in Patients treated with AvastinĀ® (bevacizumab) and sunitinib malate Dear Healthcare Provider:
Add to Reading List

Document Date: 2014-03-31 07:24:12


Open Document

File Size: 51,73 KB

Share Result on Facebook
UPDATE